ATE284683T1 - Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung - Google Patents

Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung

Info

Publication number
ATE284683T1
ATE284683T1 AT97941381T AT97941381T ATE284683T1 AT E284683 T1 ATE284683 T1 AT E284683T1 AT 97941381 T AT97941381 T AT 97941381T AT 97941381 T AT97941381 T AT 97941381T AT E284683 T1 ATE284683 T1 AT E284683T1
Authority
AT
Austria
Prior art keywords
treatment
isovaleramide
concussions
headaches
epilepsy
Prior art date
Application number
AT97941381T
Other languages
English (en)
Inventor
Linda D Artman
Manuel F Balandrin
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Application granted granted Critical
Publication of ATE284683T1 publication Critical patent/ATE284683T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
AT97941381T 1996-08-30 1997-08-29 Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung ATE284683T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2505096P 1996-08-30 1996-08-30
PCT/US1997/015272 WO1998008498A1 (en) 1996-08-30 1997-08-29 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants

Publications (1)

Publication Number Publication Date
ATE284683T1 true ATE284683T1 (de) 2005-01-15

Family

ID=21823778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97941381T ATE284683T1 (de) 1996-08-30 1997-08-29 Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung

Country Status (16)

Country Link
EP (1) EP0938304B1 (de)
JP (1) JP2000504035A (de)
KR (1) KR100594400B1 (de)
CN (2) CN1531924A (de)
AT (1) ATE284683T1 (de)
AU (1) AU728765B2 (de)
BR (1) BR9713188A (de)
CA (1) CA2264577A1 (de)
DE (1) DE69731968T2 (de)
DK (1) DK0938304T3 (de)
ES (1) ES2235251T3 (de)
HK (1) HK1023725A1 (de)
IL (1) IL128724A (de)
PT (1) PT938304E (de)
RU (1) RU2232016C2 (de)
WO (1) WO1998008498A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589994B1 (en) 1996-08-30 2003-07-08 Nps Pharmaceuticals, Inc. Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
EP1576962A1 (de) * 1998-03-04 2005-09-21 Nps Pharmaceuticals, Inc. Zusammensetzungen enthaltend Isovalerianamide zusammen mit ibuprofen
ES2242385T3 (es) * 1998-03-04 2005-11-01 Nps Pharmaceuticals, Inc. Composiciones que incluyen amina isovalerica e ibuprofeno.
AU2003204485B2 (en) * 1998-03-04 2006-06-08 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
US6383527B1 (en) * 1999-03-04 2002-05-07 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
US6346283B1 (en) * 1999-03-26 2002-02-12 Ancile Pharmaceuticals Use of valeriana for the treatment of restless leg syndrome and related disorders
US7235258B1 (en) 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
CA2387819A1 (en) * 1999-10-19 2001-04-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating cns-mediated disorders
MXPA03001458A (es) * 2000-08-17 2004-05-04 Teva Pharma Derivados de acido valproico para el tratamiento del dolor.
EP1385520A4 (de) * 2001-02-08 2007-03-21 Nps Pharma Inc Methoden und verbindungen zur behandlung von neurologischen und neuropsychiatrischen erkrankungen und zur identifizierung von verbindungen zur behandlung derselben
WO2003063605A1 (en) * 2002-02-01 2003-08-07 Eugene Science Inc. Chewing gum composition containing plant sterol for decrease of flood cholesterol levels and prevention of periodontal disease
US20060025477A1 (en) * 2004-07-22 2006-02-02 Artman Linda D Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
DE102006062264A1 (de) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
RU2460534C1 (ru) * 2011-04-15 2012-09-10 Учреждение Российская академия наук Сибирское отделение (СО РАН) Институт общей и экспериментальной биологии (ИОЭБ СО РАН) Способ получения средства, обладающего анксиолитической активностью
CN103565959B (zh) * 2013-11-06 2015-04-08 李传平 一种治疗精神分裂症的汤剂
CN103961341B (zh) * 2014-05-30 2015-12-02 杨献华 一种治疗偏头痛的药物组合物及其应用
EP3423433A4 (de) * 2016-02-29 2019-12-25 Bio-Pharm Solutions Co., Ltd. Sulfamatderivate, verfahren zur herstellung davon und deren verwendungen
KR102333460B1 (ko) * 2016-11-15 2021-12-15 경희대학교 산학협력단 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
DE2230626B2 (de) * 1972-06-22 1978-07-20 Roland Dr. 7967 Bad Waldsee Schaette Baldrianpräparat
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent

Also Published As

Publication number Publication date
BR9713188A (pt) 1999-11-03
EP0938304B1 (de) 2004-12-15
DE69731968D1 (de) 2005-01-20
AU728765B2 (en) 2001-01-18
JP2000504035A (ja) 2000-04-04
EP0938304A1 (de) 1999-09-01
ES2235251T3 (es) 2005-07-01
RU2232016C2 (ru) 2004-07-10
CN1531924A (zh) 2004-09-29
CN1235541A (zh) 1999-11-17
DK0938304T3 (da) 2005-03-14
HK1023725A1 (en) 2000-09-22
WO1998008498A1 (en) 1998-03-05
CN1152677C (zh) 2004-06-09
KR100594400B1 (ko) 2006-07-03
KR20000038194A (ko) 2000-07-05
IL128724A0 (en) 2000-01-31
CA2264577A1 (en) 1998-03-05
DE69731968T2 (de) 2005-12-22
IL128724A (en) 2003-05-29
PT938304E (pt) 2005-04-29
AU4330297A (en) 1998-03-19

Similar Documents

Publication Publication Date Title
ATE284683T1 (de) Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung
WO2000051586A3 (en) Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound
SI0725779T1 (de)
IT1304152B1 (it) Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
BG104679A (en) The use of fumaric acid derivatives in transplant medicine
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
DE69706566D1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
UA39189C2 (uk) Бактерицидний засіб, спосіб боротьби з грибковими хворобами рослин та захисту рослин від ураження грибками
PL311654A1 (en) High-dosage preparations
GEP20012414B (en) Semicarbazones Having CNS Activity and Pharmaceutical Preparations Containing the Same
ATE229533T1 (de) Nitrat-salze als arzneimittel
IL111293A0 (en) Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia
IL109982A0 (en) Pharmaceutical compositions containing isovaleramide and methods for the preparation thereof
ATE237610T1 (de) Substituierte dimere carboxamid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
ZA935086B (en) Skin regenerating cosmetic composition
AU2287197A (en) Heterocyclic compounds and their preparation and use
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.
ES2163529T3 (es) Compuestos heterociclicos y su preparacion y uso.
GR1003059B (el) Βαλσαμινοελαιολαδο προιον αναγεννησης μαλλιων
HU9303016D0 (en) Process for producing pharmaceutical compositions of antiflogistic and analgesic activity from medical plants
UA29558C2 (uk) Препарат для лікування бронхіальної астми " еуфілін-н 200"

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938304

Country of ref document: EP

REN Ceased due to non-payment of the annual fee